Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Glycomimetics Inc (GLYC)

Glycomimetics Inc (GLYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
GlycoMimetics: Q1 Earnings Snapshot

GlycoMimetics: Q1 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics: Q4 Earnings Snapshot

GlycoMimetics: Q4 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics: Q3 Earnings Snapshot

GlycoMimetics: Q3 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics: Q2 Earnings Snapshot

GlycoMimetics: Q2 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics: Q1 Earnings Snapshot

GlycoMimetics: Q1 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023

GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial...

GLYC : 0.1648 (-3.06%)
GlycoMimetics to Report First Quarter 2023 Financial Results on May 3, 2023

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2023 financial results on Wednesday, May 3, 2023, at 8:30 a.m. ET.

GLYC : 0.1648 (-3.06%)
GlycoMimetics: Q4 Earnings Snapshot

GlycoMimetics: Q4 Earnings Snapshot

GLYC : 0.1648 (-3.06%)
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022

GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial...

GLYC : 0.1648 (-3.06%)
GlycoMimetics to Report Fourth Quarter and 2022 Full Year Financial Results on March 29, 2023

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report fourth quarter and 2022 full year financial results on Wednesday, March 29, 2023, at 8:30 a.m....

GLYC : 0.1648 (-3.06%)

Barchart Exclusives

Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF?
Equity investors often overlook market seasonality. Unfortunately, seasonality is usually tied to future markets. However, there are instances where the seasonality of commodities can enhance an Exchange-Traded Fund (ETF). Two significant commodities are entering a seasonal buy that will impact an outperforming homebuilder ETF. The Federal Reserve (FED) appears ready to begin a new cycle of lower rates, which may catalyze this ETF seasonal pattern. Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar